With this partnership India becomes the 12th market in the Asia Pacific region in which Invida has been granted exclusivity for Sinclair’s dermatology and wound care brands.
Invida said it will primarily focus on commercialising Sinclair’s ranges for atopic dermatitis, seborrhoeic dermatitis and acne in India.
Sinclair Pharma CEO Chris Spooner said Sinclair will operate via its own Indian subsidiary and will manufacture locally through Encube Ethicals Pvt (Goa), an Indian topical dermatology manufacturer.
Invida CEO John Graham said he is delighted to expand their regional collaboration with Sinclair in India. This addition demonstrates the high confidence Sinclair has in Invida’s market expertise in India and throughout the region.